Stocks Consumer staples PETS
NASDAQ · Consumer staplesPetmed Express Inc (PETS)
Petmed Express Inc brought in $168.9M of revenue over the twelve months to June 30, 2026, down 20.3% from a year earlier. It posted a net loss of $29.3M. In fiscal 2026 capital spending exceeded operating cash flow by $33M. At June 30, 2026 it held $13.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Petmed Express Inc
- Net worth
- Petmed Express Inc has a market value (market cap) of $26.2M at the latest share price, and shareholders' equity of $23M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $179M (-21.1% year on year), with a net loss of $57.3M. Over the 12 months to June 30, 2026: revenue $168.9M, net loss $29.3M.
- Cash flow
- In fiscal 2026 operations used $28.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Petmed Express Inc's next report is expected around November 17, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Petmed Express Inc does
Petmed Express Inc is registered with the SEC under industry code SIC 5912 (Retail-Drug Stores and Proprietary Stores). Its shares trade on NASDAQ under the ticker PETS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $179M | -$57.3M | -$2.74 | -$33M |
| 2025 | $227M | -$6.3M | -$0.30 | -$395K |
| 2024 | $281.1M | -$7.5M | -$0.37 | -$194K |
| 2023 | $256.6M | $5.1M | $0.25 | $22.5M |
| 2022 | $272.3M | $18.7M | $0.92 | $16.7M |
| 2021 | $303.6M | $23.9M | $1.19 | $37.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PETS ranks in Consumer staples
Dividends
It paid out $21K in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2026 | $0.00 | $21K | n/a |
| 2025 | $0.00 | $181K | n/a |
| 2024 | $0.60 | $12.4M | n/a |
| 2023 | $1.20 | $24.5M | 477% |
| 2022 | $1.20 | $24.4M | 130% |
| 2021 | $1.12 | $22.7M | 95% |
Latest SEC filings
What Petmed Express Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 28, 2026
- September 28, 2026
- September 28, 2026Executive or director change8-KPetMed Express increased the share reserve for its Inducement Incentive Plan by 500,000 shares to fund equity grants for its new Chief Executive Officer.
- September 21, 2026Executive or director change8-KPetMed Express appointed Tamar Elkeles as an independent director to its Board of Directors.
- September 17, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 20% to $41M versus the same quarter last year; diluted EPS -$0.28 versus -$1.65.
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 12, 2026
- July 23, 2026
Insider trades
What the people running Petmed Express Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 28, 2026 | Willard Jeffrey AllenCEO and President, Director | Received as pay | 250,000 | - |
| September 17, 2026 | Elkeles TamarDirector | Received as pay | 49,923 | - |
| August 11, 2026 | Campbell Leslie C.G.Interim CEO and President, Director | Received as pay | 60,000 | - |
| August 11, 2026 | LaCamp JamesDirector | Received as pay | 55,555 | - |
| August 11, 2026 | Mennen Justin L.Director | Received as pay | 55,555 | - |
| August 11, 2026 | Batushansky PeterDirector | Received as pay | 55,555 | - |
| June 26, 2026 | Krulik DouglasCAO and Interim CFO | Received as pay | 32,500 | - |
| June 26, 2026 | Krulik DouglasCAO and Interim CFO | Received as pay | 32,500 | - |
Who owns PETS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| SilverCape Investments Limited13D, may seek influence with 1 related filers | 12.07% | June 29, 2026 |
| Renaissance Technologies LLC13G, passive with 1 related filers | 5.29% | August 13, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 50 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Renaissance Technologies LLC | 1,131,230 | -55,139 |
| Vanguard Capital Management LLC | 827,397 | -4,034 |
| BlackRock, Inc. | 568,255 | +16,578 |
| Federated Hermes, Inc. | 212,170 | -454,635 |
| Geode Capital Management, LLC | 204,075 | -17,447 |
| Steel Partners Holdings L.P. | 193,664 | 0 |
| UBS Group AG | 138,330 | -95,346 |
| Bridgeway Capital Management, LLC | 121,048 | -11,676 |
| Rangeley Capital, LLC | 121,000 | +11,792 |
| Vanguard Fiduciary Trust Co | 110,481 | +769 |
| State Street Corp | 105,173 | 0 |
| Formidable Asset Management, LLC | 85,551 | -19,650 |
| Empowered Funds, LLC | 82,348 | +7,324 |
| Tudor Investment Corp ET AL | 81,407 | new |
| Arrowstreet Capital, Limited Partnership | 79,503 | -47,271 |
| Citadel Advisors LLC | 74,127 | -13,767 |
| Dimensional Fund Advisors LP | 60,353 | -147,416 |
| UMB Bank, n.a. | 60,000 | 0 |
| Susquehanna International Group, Llp | 47,733 | new |
| Northern Trust Corp | 42,653 | -4,421 |
Insiders
9 insiders reported holding 3,560,345 shares in total, about $4.3M at the last price.
| Holder | Shares |
|---|---|
| Nina Capital Holdings Inc.10% owner | 2,600,000 |
| Willard Jeffrey AllenCEO and President, Director | 250,000 |
| Campbell Leslie C.G.Interim CEO and President, Director | 145,000 |
| Fulgoni GianDirector | 132,299 |
| Krulik DouglasCAO and Interim CFO | 102,500 |
| Mennen Justin L.Director | 98,274 |
| Batushansky PeterDirector | 91,928 |
| LaCamp JamesDirector | 90,421 |
| Elkeles TamarDirector | 49,923 |
Questions about PETS
What does Petmed Express Inc do?
Petmed Express Inc is a company in the Consumer staples sector, listed on NASDAQ as PETS. Its shares trade on NASDAQ under the ticker PETS.
What is Petmed Express Inc's net worth?
Petmed Express Inc has a market value (market cap) of $26.2M at the latest share price, and shareholders' equity of $23M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Petmed Express Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $29.3M on revenue of $168.9M.
How much revenue does Petmed Express Inc make?
Over the twelve months to June 30, 2026 Petmed Express Inc reported revenue of $168.9M. That is 20.3% less than a year earlier.
When did Petmed Express Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 29, 2026.
When is Petmed Express Inc's next earnings report?
Petmed Express Inc's next report is expected around November 17, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PETS with
Follow PETS
Get an email when Petmed Express Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Petmed Express Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.